Behavioral effects of dietary neurotransmitter precursors: Basic and clinical aspects

Neuroscience and Biobehavioral Reviews

Volumn 20, Issue 2, 1996, Pages 313-323

  Young, Simon N ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Acetylcholine; Aggression; Analgesia; Antidepressant; Catecholamines; Choline; Glycine; Lecithin; Phenylalanine; Serotonin; Stress; Threonine; Tryptophan; Tyrosine

Indexed keywords

ACETYLCHOLINE; ANTIDEPRESSANT AGENT; CHLORPROMAZINE; CHOLINE; DEXTRO PHENYLALANINE; DOPAMINE; GLYCINE; HISTAMINE; HISTIDINE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; NEUROTRANSMITTER; NORADRENALIN; PHENYLALANINE; PHOSPHATIDYLCHOLINE; PLACEBO; SEROTONIN; THREONINE; TRYPTOPHAN; TYROSINE;

AGGRESSION; ALZHEIMER DISEASE; AROUSAL; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR; CLINICAL TRIAL; DEPRESSION; DIETARY INTAKE; EOSINOPHILIA MYALGIA SYNDROME; HUMAN; MANIA; NAUSEA; NONHUMAN; PAIN; PRECURSOR; PRIORITY JOURNAL; SLEEP; SPASTICITY; TARDIVE DYSKINESIA;

EID: 0029738854     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/0149-7634(95)00022-4     Document Type: Article

References (142)

1. 1. Abbott, F. V.; Young, S. N. The effect of tryptophan supplementation on autotomy induced by nerve lesions in rats. Pharmacol. Biochem. Behav. 40:301-304; 1991.
2. 2. Åsberg, M.; Schalling, D.; Träskman-Bendz, L.; Wägner, A. Psychobiology of suicide, impulsivity, and related phenomena. In: Meltzer, H. Y., ed. Psychopharmacology: The third generation of progress. New York: Raven Press; 1987:655-668.
3. 3. Ayuso Gutierrez, J. L.; Lopez-Ibor Alino, J. J. Tryptophan and an MAOI (nialamide) in the treatment of depression. Int. Pharmacopsychiatry 6:92-97; 1971.
4. 4. Balagot, R. C.; Ehrenpreis, S.; Greenberg, J.; Hyodo, M. D-Phenylalanine in human chronic pain. In: Ehrenpreis, S.; Sicuteri, F., eds. Degradation of endogenous opioids: Its relevance in human pathology and therapy. New York: Raven Press; 1983:207-215.
5. 5. Baldessarini, R. J. Treatment of depression by altering monoamine metabolism: precursors and metabolic inhibitors. Psychopharmacol. Bull. 20:224-239; 1984.
6. 6. Baldessarini, R. J.; Tarsy, D. Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs. Annu. Rev. Neurosci. 3:23-41; 1980.
7. 7. Banderet, L. E.; Lieberman, H. R. Treatment with tyrosine, a neurotransmitter precursor, reduces environmental stress in humans. Brain Res. Bull. 22:759-762; 1989.
8. 8. Barbeau, A. Emerging treatments: replacements therapy with choline or lecithin in neurological diseases. Can. J. Neurol. Sci. 5:157-160; 1978.
9. 9. Bartus, R. T.; Dean, R. L.; Beer, B.; Lippa, A. S. The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408-414; 1982.
10. 10. Beckmann, H.; Athen, D.; Olteanu, M.; Zimmer, R. DL-Phenylalanine versus imipramine: A double-blind controlled study. Arch. Psychiat. Nervenkr. 227:49-58; 1979.
11. 11. Beckmann, H.; Strauss, M. A.; Ludolph, E. DL-Phenylalanine in depressed patients: An open study. J. Neural Transm. 41:123-134; 1977.
12. 12. Belongia, E. A.; Hedberg, C. W.; Gleich, G. J.; White, K. E.; Mayeno, A. N.; Loegering, D. A.; Dunnette, S. L.; Pirie, P. L.; MacDonald, K. L.; Osterholm, M. T. An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. N. Engl. J. Med. 323:357-365; 1990.
13. 13. Birkmayer, W.; Riederer, P.; Linauer, W.; Knoll, J. L-Deprenyl plus L-phenylalanine in the treatment of depression. J. Neural Transm. 59:81-87; 1984.
14. 14. Blum, K.; Trachtenberg, M. C.; Cook, D. W. Neuronutrient effects on weight loss in carbohydrate bingers: An open clinical trial. Curr. Ther. Res. 48:217-233; 1990.
15. 15. Blundell, J. E. Serotonin and appetite. Neuropharmacology 23:1537-1551; 1984.
16. 16. Blusztajn, J. K.; Wurtman, R. J. Choline and cholinergic neurons. Science 221:614-620; 1983.
17. 17. Borison, R. L.; Maple, P. J.; Havdala, H. S.; Diamond, B. I. Metabolism of an amino acid with antidepressant properties. Res. Commun. Chem. Pathol. Pharmacol. 21:363-366; 1987.
18. 18. Boulton, A. A. Trace amines in the central nervous system. In: Tipton, K. F., ed. International review of biochemistry: Physiological and pharmacological biochemistry. Baltimore: University Park Press; 1979:179-206.
19. 19. Brady, K.; Brown, J. W.; Thurmond, J. B. Behavioral and neurochemical effects of dietary tyrosine in young and aged mice following cold-swim stress. Pharmacol. Biochem. Behav. 12:667-674; 1980.
20. 20. Branchey, M. H.; Branchey, L. B.; Bark, N. M.; Richardson, M. A. Lecithin in the treatment of tardive dyskinesia. Commun. Psychopharmacol. 3:303-307; 1979.
21. 21. Brewerton, T. D.; Murphy, D. L.; Jimerson, D. C. Testmeal responses following m-chlorophenylpiperazine and L-tryptophan in bulimics and controls. Neuropsychopharmacology 11:63-71; 1994.
22. 22. Brückner, H.; Hausch, M. Detection of free D-amino acids in food by chiral phase capillary gas chromatography. J. High Res. Chromatogr. 12:680-684; 1989.
23. 23. Canty, D. J.; Zeisel, S. H. Lecithin and choline in human health and disease. Nutr. Rev. 52:327-339; 1994.
24. 24. Carboni, E.; Cadoni, C.; Tanda, G. L.; Di Chiara, G. Calcium-dependent, tetrodotoxin-sensitive stimulation of cortical serotonin release after a tryptophan load. J. Neurochem. 53:976-978; 1989.
25. 25. Carlsson, A.; Lindqvust, M. Dependence of 5HT and catecholamine synthesis on concentrations of precursor amino acids in rat brain. Naunyn Schmiedebergs Arch. Pharmacol. 303:157-164; 1978.
26. 26. Castagné, V.; Finot, P. A.; Maire, J. C. Effects of diet-induced hyperthreoninemia. (II) Tissue and extracellular amino acid levels in the brain. Life Sci. 54:41-48; 1993.
27. 27. Ceccherelli, F.; Diani, M. M.; Altafini, L.; Varotto, E.; Stefecius, A.; Casale, R.; Costola, A.; Giron, G. P. Postoperative pain treated by intravenous L-tryptophan: A double-blind study versus placebo in cholecystectomized patients. Pain 47:163-172; 1991.
28. 28. Chambers, C. A.; Naylor, G. J. A controlled trial of L-tryptophan in mania. Br. J. Psychiatry 132: 555-559; 1978.
29. 29. Chouinard, G.; Young, S. N.; Annable, L. A controlled clinical trial of L-tryptophan in acute mania. Biol. Psychiatry 20:546-557; 1984.
30. 30. Cohen, B. M.; Lipinski, J. F.; Altesman, R. I. Lecithin in the treatment of mania: double-blind, placebo-controlled trials. Am. J. Psychiatry 139:1162-1164; 1982.
31. 31. Cole, J. O.; Hartmann, E.; Brigham, P. L-Tryptophan: clinical studies. In: Cole, J. O., ed. Psychopharmacology update. Lexington, MA: Collamore Press; 1980:119-148.
32. 32. Conlay, L. A.; Maher, T. J.; Moses, P. L.; Wurtman, R. J. Tyrosine's vasoactive effect in the dog shock model depends on the animal's starting blood pressure. J. Neural Transm. 58:69-74; 1983.
33. 33. Coppen, A.; Shaw, D. M.; Farrell, J. P. Potentiation of the antidepressive effect of a monoamine-oxidase inhibitor by tryptophan. Lancet i:79-81; 1963.
34. 34. Davis, K. L.; Berger, P. A.; Hollister, L. E. Choline for tardive dyskinesia. N. Engl. J. Med. 293:152; 1975.
35. 35. Deijen, J. B.; Orlebeke, J. F. Effect of tyrosine on cognitive function and blood pressure under stress. Brain Res. Bull. 33:319-323; 1994.
36. 36. Eccleston, D.; Ashcroft, G. W.; Crawford, T. B. B.; Stanton, J. B.; Wood, D.; McTurk, P. H. Effect of tryptophan administration on 5HIAA in cerebrospinal fluid in man. J. Neurol. Neurosurg. Psychiatry 33:269-272; 1970.
37. 37. Ehrenpreis, S.; Balagot, R. C.; Greenberg, J.; Myles, S.; Ellyin, F. Analgesic and other pharmacological properties of D-phenylalanine. In: Ehrenpreis, S.; Sicuteri, F., eds. Degradation of endogenous opioids: Its relevance in human pathology and therapy. New York: Raven Press; 1983:171-187.
38. 38. Ekblom, A.; Hansson, P.; Thomsson, M. L-Tryptophan supplementation does not affect postoperative pain intensity or consumption of analgesics. Pain 44:249-254; 1991.
39. 39. Elwes, R. D. C.; Chesterman, L. P.; Jenner, P.; Crewes, H.; Summers, B.; Binnie, C. D.; Parkes, J. D. Treatment of narcolepsy with L-tyrosine: Double-blind placebo-controlled trial. Lancet ii:1067-1069; 1989.
40. 40. Fernstrom, J. D.; Wurtman, R. J. Brain serotonin content: Physiological dependence on plasma tryptophan levels. Science 173:149-152; 1971.
41. 41. Frank, J.; Winkleby, M. A.; Fortmann, S. P.; Rockhill, B.; Farquhar, J. W. Improved cholesterol-related knowledge and behavior and plasma cholesterol levels in adults during the 1980s. J. Am. Med. Assoc. 268:1566-1572; 1992.
42. 42. Franklin, K. B. J.; Abbott, F. V.; English, M. J. M.; Jeans, M. E.; Tasker, R. A. R.; Young, S. N. Tryptophan-morphine interactions and postoperative pain. Pharmacol. Biochem. Behav. 35:157-163; 1990.
43. 43. Gelenberg, A. J.; Doller-Wojcik, J. C.; Growdon, J. H. Choline and lecithin in the treatment of tardive dyskinesia: preliminary results from a pilot study. Am. J. Psychiatry 136:772-776; 1979.
44. 44. Gelenberg, A. J.; Gibson, C. J.; Wojcik, J. D. Neurotransmitter precursors for the treatment of depression. Psychopharmacol. Bull. 18:7-18; 1982.
45. 45. Gelenberg, A. J.; Wojcik, J. D.; Falk, W. E.; Baldessarini, R. J.; Zeisel, S. H.; Schoenfeld, D.; Mok, G. S. Tyrosine for depression: A double-blind study. J. Affective Disord. 19:125-132; 1990.
46. 46. Glaeser, B. S.; Maher, T. J.; Wurtman, R. J. Changes in brain levels of acidic, basic, and neutral ammo acids after consumption of single meals containing various proportions of proteins. J. Neurochem. 41:1016-1021; 1983.
47. 47. Glassman, A. H.; Platman, S. R. Potentiation of a monoamine oxidase inhibitor by tryptophan. J. Psychiat. Res. 7:83-88; 1969.
48. 48. Goldberg, I. K. L-Tyrosine in depression. Lancet ii:364-365; 1980.
49. 49. Goodfraind, J. M.; Plaghki, L.; De Nayer, J. A comparative study on the effects of D-phenylalanine, lysozyme and zimelidine in human lubosacral arachno-epiduritis, a chronic pain state. In: Bromm, B., ed. Pain measurement in man: Neurophysiological correlates of pain. New York: Elsevier; 1984:501-511.
50. 50. Growdon, J. H.; Hirsch, M. J.; Wurtman, R. J.; Weiner, W. Oral choline administration to patients with tardive dyskinesia. N. Engl. J. Med. 297:524-527; 1977.
51. 51. Growdon, J. H.; Melamed, E.; Logue, M.; Hefti, F.; Wurtman, R. J. Effect of oral L-tyrosine administration on CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease. Life Sci. 30:827-332; 1982.
52. 52. Growdon, J. H.; Nader, T. M.; Schoenfeld, J.; Wurtman, R. J. L-Threonine in the treatment of spasticity. Clin. Neuropharmacol. 14:403-412; 1991.
53. 53. Hajak, G.; Huether, G.; Blanke, J.; Blomer, M.; Freyer, C.; Poeggeler, B.; Reimer, A.; Rodenbeck, A.; Schulzvarszegi, M.; Ruther, E. The influence of intravenous L-tryptophan on plasma melatonin and sleep in men. Pharmacopsychiatry 24:17-20; 1991.
54. 54. Halpern, L. M.; Dong, W. K. D-Phenylalanine: A putative enkephalinase inhibitor studied in a primate acute pain model. Pain 24:223-220; 1986.
55. 55. Harris, B. Prospective trial of L-tryptophan in maternity blues. Br. J. Psychiatry 137:223-235, 1980.
56. 56. Hartmann, E.; Cravens, J.; List, S. Hypnotic effects of L-tryptophan. Arch. Gen. Psychiatry 31:394-397; 1974.
57. 57. Hartmann, E.; Greenwald, D. Tryptophan and human sleep: An analysis of 43 studies. In: Schlossberger, H. G.; Kochen, W.; Linzen, B.; Steinhart, H., eds. Progress in tryptophan and serotonin research. Berlin: Walter de Gruyter; 1984:297-304.
58. 58. Hartmann, E.; Spinweber, C. L.; Ware, C. L-Tryptophan, L-leucine, and placebo: Effects on subjective alertness. Sleep Res. 5:57; 1976.
59. 59. Harvey, J. A.; Simansky, K. J. The role of serotonin in modulation of nociceptive reflexes. In: Gabay, S.; Issirorides, M. R.; Alivisatos, S. G. A., eds. Serotonin: Current aspects of neurochemistry and function, vol. 133, Advances in experimental medicine and biology. New York: Plenum Press; 1981:125-151.
60. 60. Hauser, S. L.; Doolittle, T. H.; Lopez-Bresnahan, M.; Shahani, B.; Schoenfeld, D.; Shih, V. E.; Growdon, J. H.; Lehrich, J. R. An antispasticity effect of threonine in multiple sclerosis. Arch. Neurol. 49:923-926; 1992.
61. 61. Héroux, O.; Roberge, A. G. Different influences of two types of diets commonly used for rats on a series of parameters related to the metabolism of central serotonin and noradrenaline. Can. J. Physiol. Pharmacol. 59:108-112; 1980.
62. 62. Hess, S. M.; Doepfner, W. Behavioral effects and brain amine content in rats. Arch. Int. Pharmacodyn. Ther. 134:89-99; 1961.
63. 63. Hill, A. J.; Blundell, J. E. Role of amino acids in appetite control in man. In: Huether, G., ed. Amino acid availability and brain function in health and disease: NATO ASI Series H, Cell biology, vol. 20. Berlin: Springer; 1988:239-248.
64. 64. Hrboticky, N.; Leiter, L. A.; Anderson, G. H. Effects of L-tryptophan on short term food intake in lean men. Nutr. Res. 5:595-607; 1985.
65. 65. Imura, K.; Kamata, S.; Hata, A.; Okada, A.; Watanabe, T.; Wada, H. Effects of dietary histidine and methionine loading in rats with a portacaval shunt. Pharmacol. Biochem. Behav. 24:1323-1328; 1986.
66. 66. Itoh, Y.; Oishi, R.; Nishibori, M.; Saeki, K.; Furuno, K.; Fukuda, T.; Araki, Y. Lack of evidence for the involvement of catecholaminergic mechanisms in the behavioral anti-methamphetamine effect of L-histidine in the mouse. Pharmacol. Biochem. Behav. 24:571-574; 1986.
67. 67. Jackson, D. A.; Kischka, U.; Wurtman, R. J. Choline enhances scopolamine-induced acetylcholine release in dorsal hippocampus of conscious, freely-moving rats. Life Sci. 56:45-49; 1994.
68. 68. Jackson, I. V.; Nutall, E. A.; Ibe, I. O.; Perez-Cruet, J. Treatment of tardive dyskinesia with lecithin, Am. J. Psychiatry 136:1458-1460; 1979.
69. 69. Janowsky, D. S.; Risch, S. C. Cholinometic and anticholinergic drugs used to investigate an acetylcholine hypothesis of affective disorders and stress. Drug Devel. Res. 4:125-142; 1984.
70. 70. Kaplan, J. R.; Shivery, C. A.; Fontenot, M. B.; Morgan, T. M.; Howell, S. M.; Manuck, S. B.; Muldoon, M. F.; Mann, J. J. Demonstration of an association among dietary cholesterol, central serotonergic activity, and social behavior in monkeys. Psychosom. Med. 56:479-484; 1994.
71. 71. King, R. B. Pain and tryptophan. J. Neurosurg. 53:44-52; 1980.
72. 72. Kitade, T.; Minamikawa, M.; Nawata, T.; Shinohara, S.; Hyodo, M.; Hosoya, E. An experimental study on the enhancing effects of phenylalanine on acupuncture analgesia. Am. J. Clin. Med. 9:243-248; 1981.
73. 73. Ladd, S. L.; Sommer, S. A.; Laberge, S.; Toscano, W. Effect of phosphatidylcholine on explicit memory. Clin. Neuropharmacol. 16:540-549; 1993.
74. 74. Lader, M. The return of L-tryptophan. Hum. Psychopharmacology 9:365-366; 1994.
75. 75. Lauer, J. W.; Inskip, W. M.; Bernsohn, J.; Zeller, E. A. Observations on schizophrenic patients after iproniazid and tryptophan. A. M. A. Arch. Neurol. Psychiatr. 80:122-130; 1958.
76. 76. Le Bars, D. Serotonin and pain. In: Osborne, N. N.; Hamon, M., eds. Neuronal serotonin. New York: Wiley; 1988:171-229.
77. 77. Leathwood, P. D. Neurotransmitter precursors: From animal experiments to human applications. Nutr. Rev. 44:193-204; 1986.
78. 78. Leathwood, P. D.; Pollet, P. Diet-induced mood changes in normal populations. J. Psychiat. Res. 17:147-154; 1983.
79. 79. Lehmann, W. D.; Theobald, N.; Fischer, R.; Heinrich, H. C. Stereospecificity of phenylalanine plasma kinetics and hydroxylation in man following oral application of a stable isotope-labelled pseudo-racemic mixture of L- and D-phenylalanine. Clin. Chim. Acta 128:181-198; 1983.
80. 80. Lehnert, H.; Reinstein, D. K.; Strowbridge, B. W.; Wurtman, R. J. Neurochemical and behavioral consequences of acute uncontrollable stress: Effects of dietary tyrosine. Brain Res. 303:215-223; 1984.
81. 81. Lieberman, H. R.; Corkin, S.; Spring, B. J.; Growdon, J. H.; Wurtman, R. J. Mood, performance, and pain sensitivity: Changes induced by food constituents. J. Psychiat. Res. 17:135-145; 1983.
82. 82. Innoila, M.; Virkkunen, M. Biologic correlates of suicidal risk and aggressive behavioral traits. J. Clin. Psychopharmacol. 12:S19-S20; 1992.
83. 83. Maher, T. J.; Wurtman, R. J. L-Threonine administration increases glycine concentrations in the rat central nervous system. Life Sci. 26:1283-1286; 1980.
84. 84. Mann, J. J.; Peselow, E. D.; Snyderman, S.; Gershon, S. D-Phenylalanine in endogenous depression. Am. J. Psychiatry 137:1611-1612; 1980.
85. 85. Marshall, D. L.; Wurtman, R. J. Effect of choline on basal and stimulated acetylcholine release. An in vivo microdialysis study using a low neostigmine concentration. Brain Res. 629:269-274; 1993.
86. 86. Mawson, A. R.; Jacobs, K. W. Corn consumption, tryptophan, and cross-national homicide rates. J. Orthomolec. Psychiatry 7:227-230; 1978.
87. 87. McGee, C. D.; Greenwood, C. E. Effects of dietary fatty acid composition on macronutrient selection and synaptosomal fatty acid composition in rats. J. Nutr. 119:1561-1568; 1989.
88. 88. McGee, C. D.; Greenwood, C. E.; Cinader, B. Dietary fat composition and age affect synaptosomal and retinal phospholipid fatty acid composition in C57BL/6 mice. Lipids 29:605-619; 1994.
89. 89. McGrath, R. E.; Buckwald, B.; Resnick, E. V. The effect of L-tryptophan on seasonal affective disorder. J. Clin. Psychiatry 51:162-163; 1990.
90. 90. Milner, J. D.; Wurtman, R. J. Catecholamine synthesis: physiological coupling to precursor supply. Biochem. Pharmacol. 35:875-881; 1986.
91. 91. Mitchell, M. J.; Daines, G. E.; Thomas, B. Effect of L-tryptophan and phenylalanine on burning pain threshold. Physical Ther. 67:203-205; 1987.
92. 92. Moldofsky, H.; Lue, F. A. The relationship of alpha and delta EEG frequencies to pain and mood in 'fibrositis' patients treated with chlorpromazine and L-tryptophan. EEG Clin. Neurophysiol. 50:71-80; 1980.
93. 93. Morand, C.; Young, S. N.; Ervin, F. R. Clinical response of aggressive schizophrenics to oral tryptophan. Biol. Psychiatry 18:575-578; 1983.
94. 94. Mouret, J.; Lemoine, P.; Minuit, M. P.; Robelin, N. La L-tyrosine guérit, immédiatement et à long terme, les dépressions dopamino-dépendantes (DDD). Étude clinique et polygraphique. C. R. Acad. Sci. 306:93-98; 1988.
95. 95. Muldoon, M. F.; Manuck, S. B.; Mathews, K. M. Lowering cholesterol concentration and mortality: A quantitative review of primary prevention trials. Br. Med. J. 301:309-314; 1990.
96. 96. Murphy, D. L.; Baker, M.; Goodwin, F. K.; Miller, H.; Kotin, J.; Bunney, W. E. L-Tryptophan in affective disorders: Indoleamine changes and differential clinical effects. Psychopharmacologia 34:11-20; 1974.
97. 97. Nightingale, S. L. Update on EMS and L-tryptophan. J. Am. Med. Assoc. 268:1828; 1992.
98. 98. Oberlander, T. F.; Barr, R. G.; Young, S. N.; Brian, J. A. Short-term effects of feed composition on sleeping and crying in newborns. Pediatrics 90:733-740; 1992.
99. 99. Onodera, K.; Yamatodani, A.; Watanabe, T.; Wada, H. Neuropharmacology of the histaminergic system of the brain and its relationship with behavioral disorders. Prog. Neurobiol. 42:685-702; 1994.
100. 100. Owasoyo, J. O.; Neri, D. F.; Lamberth, J. G. Tyrosine and its potential use as a countermeasure to performance decrement in military sustained operations. Aviat. Space. Environ. Med. 63:364-369; 1992.
101. 101. Pare, C. M. B. Potentiation of monoamine-oxidase inhibitors by tryptophan. Lancet ii:527-528; 1963.
102. 102. Pile, A.; Rogoz, Z.; Skuza, G. Histidine-induced bizarre behavior in rats: The possible involvement of central cholinergic system. Neuropharmacology 21:781-785; 1982.
103. 103. Prange, A. J.; Wilson, I. C.; Lynn, C. W. L-Tryptophan in mania: Contribution to a permissive hypothesis of affective disorders. Arch. Gen. Psychiatry 30:56-62; 1974.
104. 104. Sabelli, H. C.; Fawcett, J.; Gusovsky, F.; Javaid, J. I.; Wynn, P.; Edwards, J.; Jeffries, H.; Kravitz, H. Clinical studies on the phenylethylamine hypothesis of affective disorder: Urine and blood phenylacetic acid and phenylalanine dietary supplements. J. Clin. Psychiatry 47:66-70; 1986.
105. 105. Schreier, H. A. Mania responsive to lecithin in a 13-year-old girl. Am. J. Psychiatry 139:108-110; 1982.
106. 106. Schwartz, D. H.; Hernandez, L.; Hoebel, B. G. Tryptophan increases extracellular serotonin in the lateral hypothalamus of food-deprived rats. Brain Res. Bull. 25:803-807; 1990.
107. 107. Seltzer, S.; Dewart, D.; Pollack, R. L.; Jackson, E. J. The effects of dietary tryptophan on chronic maxillofacial pain and experimental pain tolerance. J. Psychiat. Res. 17:181-185; 1983.
108. 108. Seltzer, S.; Stoch, R.; Marcus, R.; Jackson, E. J. Alteration of human pain thresholds by nutritional manipulation and L-tryptophan supplementation. Pain 13:385-392; 1982.
109. 109. Sharp, T.; Bramwell, S. R.; Grahame-Smith, D. G. Effect of acute administration of L-tryptophan on the release of 5-HT in rat hippocampus in relation to serotoninergic neuronal activity: an in vivo microdialysis study. Life Sci. 5:1215-1223; 1992.
110. 110. Shpeen, S. E.; Morse, D. R.; Furst, M. L. The effect of tryptophan on postoperative endodontic pain. Oral Surg. 58:446-449; 1984.
111. 111. Shurtleff, D.; Thomas, J. R.; Schrot, J.; Kowalski, K.; Harford, R. Tyrosine reverses a cold-induced working memory deficit in humans. Pharmacol. Biochem. Behav. 47:935-941; 1994.
112. 112. Simon, R.; Wetzel, W.; Winsey, K.; Levenson, S. M.; Demetriou, A. A. Supplemental dietary tyrosine in sepsis and acute hemorrhagic shock. Arch. Surg. 122:78-81; 1987.
113. 113. Sole, M. J.; Benedict, C. R.; Myers, M. G.; Leenen, F. H.; Anderson, G. H. Chronic dietary tyrosine supplements do not affect mild essential hypertension. Hypertension 7:593-596; 1985.
114. 114. Sourkes, T. L. Toxicology of monoamine precursors. In: van Praag, H. M.; Mendlewicz, J., eds. Management of depressions with monoamine precursors, vol. 10. Advances in biological psychiatry. Basel: Karger; 1983:160-175:
115. 115. Spatz, H.; Heller, B.; Nachon, M.; Fischer, E. Effects of D-phenylalanine on clinical picture and phenylethylaminuria in depression. Biol. Psychiatry 10:235-239; 1975.
116. 116. Spring, B. J.; Maller, O.; Wurtman, J. J.; Digman, L.; Cozolino, L. Effects of protein and carbohydrate meals on mood and performance: interactions with sex and age. J. Psychiat. Res. 17:155-167; 1983.
117. 117. Sternbach, R. A.; Janowsky, D. S.; Huey, L. Y.; Segal, D. S. Effects of altering brain serotonin activity on human chronic pain. In: Bonica, J. J.; Albe-Fessard, D., eds. Advances in pain research and therapy. New York: Raven Press; 1976:601-606.
118. 118. Strain, G. W.; Strain, J. J.; Zumoff, B. L-Tryptophan does not increase weight loss in carbohydrate-craving obese subjects. Int. J. Obes. 9:375-380; 1985.
119. 119. Tamminga, C. A.; Smith, R. C.; Ericksen, S. E .; Chang, S.; Davis, J. M. Cholinergic influences in tardive dyskinesia. Am. J. Psychiatry 134:769-774; 1977.
120. 120. Taylor, K. M.; Snyder, S. H. Dynamics of the regulation of histamine levels in mouse brain. J. Neurochem. 19:341-354; 1972.
121. 121. Teff, K. L.; Young, S. N.; Marchand, L.; Botez, M. I. Acute effect of protein and carbohydrate breakfasts on human cerebrospinal fluid monoamine precursor and metabolite levels. J. Neurochem. 52:235-241; 1989.
122. 122. Thomson, J.; Rankin, H.; Ashcroft, G. W.; Yates, C. M.; McQueen, J. K.; Cummings, S. W. The treatment of depression in general practice: A comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo. Psychol. Med. 12:741-751; 1982.
123. 123. Tokuhisa, S.; Saisu, K.; Naruse, K.; Yoshikawa, H.; Baba, S. Studies on phenylalanine metabolism by tracer techniques. IV. Biotransformation of D- and L-phenylalanine in man. Chem. Pharm. Bull. 29:514-518; 1981.
124. 124. Trulson, M. E.; Jacobs, B. L. Dose-response relationship between systemically administered L-tryptophan or L-5-hydroxytryptophan and raphe unit activity in the rat. Neuropharmacology 15:339-344; 1976.
125. 125. Trulson, M. E.; Jacobs, B. L. Raphe unit activity in freely moving cats: Correlation with level of behavioral arousal. Brain Res. 163:135-150; 1979.
126. 126. Tsukada, H.; Lindner, K. J.; Hartvig, P.; Langstrom, B. Effect of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin on the extracellular levels of dopamine and serotonin in the rat striatum: A microdialysis study with tyrosine or tryptophan infusion. Brain Res. 635:59-67; 1994.
127. 127. van Praag, H. M. Management of depression with serotonin precursors. Biol. Psychiatry 16:291-310; 1981.
128. 128. van Praag, H. M. Catecholamine precursor research in depression: The practical and scientific yield. In: Richardson, M. A., ed. Amino acids in psychiatric disease. Washington: American Psychiatric Press; 1990:77-97.
129. 129. Varga, J.; Uitto, J.; Jimenez, S. A. The cause and pathogenesis of the eosinophilia-myalgia syndrome. Ann. Intern. Med. 116:140-147; 1992.
130. 130. Volavka, J.; Crowner, M.; Brizer, D.; Convit, A.; van Praag, H. M.; Suckow, R. F. Tryptophan treatment of aggressive psychiatric inpatients. Biol. Psychiatry 28:728-732; 1990.
131. 131. Wada, H.; Inagaki, N.; Yamatodani, A.; Watanabe, T. Is the histaminergic neuron system a regulatory center for whole-brain activity? Trends Neurosci 14:415-418; 1991.
132. 132. Walsh, N. E.; Ramamurthy, S.; Schoenfeld, L.; Hoffman, J. Analgesic effectiveness of D-phenylalanine in chronic pain patients. Arch. Phys. Med. Rehabil. 67:436-439; 1986.
133. 133. Westerink, B. H. C.; De Vries, J. B. Effect of precursor loading on the synthesis rate and release of dopamine and serotonin in the striatum: A microdialysis study in conscious rats. J. Neurochem. 56:228-233; 1991.
134. 134. Wilkins, K. Eosinophilia-myalgia syndrome. Can. Med. Assoc. J. 142:1265-1266; 1990.
135. 135. Wood, D. R.; Reimherr, F. W.; Wender, P. H. Treatment of attention deficit disorder with DL-phenylalanine. Psychiatry Res. 16:21-26; 1985.
136. 136. Woods, S. K.; Meyer, J. S. Exogenous tyrosine potentiates the methylphenidate-induced increase in extracellular dopamine in the nucleus accumbens: A microdialysis study. Brain Res. 560:97-105; 1991.
137. 137. Wurtman, J. J.; Wurtman, R. J.; Growdon, J. H.; Henry, P.; Lipscomb, A.; Zeisel, S. H. Carbohydrate craving in obese people: suppression by treatments affecting serotoninergic transmission. Int. J. Eating Disord. 1:2-15; 1981.
138. 138. Wurtman, R. J.; Hefti, F.; Melamed, E. Precursor control of neurotransmitter synthesis. Pharmacol. Rev. 32:315-335; 1981.
139. 139. Young, S. N. The significance of tryptophan, phenylalanine, tyrosine, and their metabolites in the nervous system. In: Lajtha, A., ed. Handbook of neurochemistry, vol. 3. New York: Plenum; 1983:559-581.
140. 140. Young, S. N. The clinical psychopharmacology of tryptophan. In: Wurtman, R. J.; Wurtman, J. J., eds. Nutrition and the brain, vol. 7, Food constituents affecting normal and abnormal behaviors. New York: Raven Press; 1986:49-88.
141. 141. Young, S. N. Use of amine precursors in combination with other antidepressant treatments: A review. J. Psychiatr. Neurosci. 16:241-246; 1991.
142. 142. Young, S. N.; Gauthier, S. Effect of tryptophan administration on tryptophan, 5-hydroxyindoleacetic acid, and indoleacetic acid in human lumbar and asternal cerebrospinal fluid. J. Neurol. Neurosurg. Psychiatry 44:323-327; 1981.